Jerzy Hohendorff

Dr. Jerzy Hohendorff is an Assistant Professor in the Department of Endocrinology at Jagiellonian University's Faculty of Medicine in Krakow, Poland. He is affiliated with University Hospital in Krakow where he conducts clinical research focused on diabetes management, endocrinology, and the intersection of metabolic disorders with emerging health crises like the COVID-19 pandemic. His work combines clinical practice with academic research, contributing significantly to the understanding of diabetes care in Polish populations.

Dr. Hohendorff's research interests center on diabetes pathophysiology, continuous glucose monitoring technologies, and the impact of comorbidities on diabetes outcomes. His work spans clinical trials investigating new monitoring approaches, epidemiological studies examining diabetes during the pandemic, and genetic research into monogenic forms of diabetes. He has made notable contributions to understanding how continuous glucose monitoring affects patient psychology, particularly regarding fear of hypoglycemia, and how these technologies can be optimized for better glycemic control.

His publication record shows a strong focus on Type 1 diabetes management, with particular attention to real-world data from Polish populations. A significant portion of his recent work has examined the intersection of diabetes with COVID-19, analyzing mortality risks, clinical outcomes, and changes in outpatient care during the pandemic. His research consistently bridges clinical practice with academic inquiry, producing actionable insights for diabetes care providers.

Dr. Hohendorff collaborates extensively with researchers at Jagiellonian University Medical College and University Hospital in Krakow, particularly with Professor Małecki MT's research group. His work appears in high-impact endocrinology and general medical journals including Frontiers in Endocrinology, Scientific Reports, and Polish Archives of Internal Medicine.